Protagonist Therapeutics (PTGX) Other Gross PP&E Adjustments (2017 - 2025)
Protagonist Therapeutics (PTGX) has disclosed Other Gross PP&E Adjustments for 9 consecutive years, with -$9.9 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments rose 9.35% to -$9.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$9.9 million through Dec 2025, up 9.35% year-over-year, with the annual reading at -$9.9 million for FY2025, 9.35% up from the prior year.
- Other Gross PP&E Adjustments hit -$9.9 million in Q4 2025 for Protagonist Therapeutics, down from $2.2 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $5.8 million in Q4 2023 to a low of -$11.0 million in Q4 2024.
- Historically, Other Gross PP&E Adjustments has averaged -$270200.0 across 5 years, with a median of $1.4 million in 2022.
- Biggest five-year swings in Other Gross PP&E Adjustments: soared 753.37% in 2022 and later tumbled 287.42% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at $386000.0 in 2021, then skyrocketed by 753.37% to $3.3 million in 2022, then soared by 77.38% to $5.8 million in 2023, then crashed by 287.42% to -$11.0 million in 2024, then rose by 9.35% to -$9.9 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for PTGX at -$9.9 million in Q4 2025, $2.2 million in Q3 2025, and $2.4 million in Q2 2025.